Sign in

CIK 0001730430

  • Large accelerated filer

Kiniksa Pharmaceuticals International, plc

Sign in to watch
Ticker
KNSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981795578
Phone
+1 781-431-9100
Business address
105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
Former names
Kiniksa Pharmaceuticals, Ltd.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$78,588,440
in 8 filings, $78.6M under 10b5-1 plans

Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2019-09-17 Mahoney Stephen F. President & COO Grant or award · Share Option +82,000 82,000
2019-03-04 Mahoney Stephen F. President & COO Grant or award · Share Option +83,000 83,000
2018-09-20 Mahoney Stephen F. President & COO Grant or award · Share Option +50,000 50,000
2018-05-29 Mahoney Stephen F. President & COO Conversion +6,392 79,589
2018-05-29 Mahoney Stephen F. President & COO Conversion · Series A Preferred Shares −107,050 0
2018-05-29 Mahoney Stephen F. President & COO Conversion · Series C Preferred Shares −6,392 0
2018-05-29 Mahoney Stephen F. President & COO Conversion · Class B Common Shares +107,050 656,027
2018-02-09 Mahoney Stephen F. President & COO Purchase · Series C Preferred Shares +6,392 $15.64 $100K 6,392

Page 1 of 1 · 8 trades